Journal article
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
Abstract
Purpose: With the integration of immunotherapy (IO) agents in the management of metastatic renal cell carcinoma (mRCC), there has been interest in the combined use with radiation therapy (RT). However, real world data are limited. The purpose of this study was to evaluate outcomes in patients with mRCC receiving both RT and IO compared with IO alone.
Methods and Materials: Data were collected from Canadian Kidney Cancer Information System from …
Authors
Nguyen EK; Lalani AKA; Ghosh S; Basappa NS; Kapoor A; Hansen AR; Kollmannsberger C; Heng D; Wood LA; Castonguay V
Journal
Advances in Radiation Oncology, Vol. 7, No. 4,
Publisher
Elsevier
Publication Date
July 2022
DOI
10.1016/j.adro.2022.100899
ISSN
2452-1094